| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $418.4M | — | +17.3% |
| Cost of Revenue | $76.9M | — | +20.5% |
| Gross Profit | $341.5M | — | +16.6% |
| R&D Expense | $92.9M | — | -2.0% |
| SG&A Expense | $52.7M | — | -3.6% |
| Operating Income | $28.0M | — | +270.5% |
| Pre-tax Income | $41.0M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $632.2M | -27.4% | -9.8% |
| Short-term Investments | $675.0M | +12.3% | -21.0% |
| Accounts Receivable | $300.0M | -38.6% | +12.5% |
| Current Assets | $1.92B | -14.5% | -9.1% |
| Total Assets | $2.90B | -8.6% | +9.8% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $131.9M | — | +10.9% |
| Capital Expenditures | $2.7M | — | -79.1% |
| Investing Cash Flow | -$112.8M | — | -41.2% |
| Financing Cash Flow | -$252.2M | — | -7.2% |
| Free Cash Flow | $129.2M | — | +21.7% |
| +307.7% |
| Income Tax | $18.4M | — | +552.4% |
| Net Income | $22.5M | — | +199.9% |
| EPS (Basic) | $0.04 | — | +200.0% |
| EPS (Diluted) | $0.04 | — | +200.0% |
| $831.7M |
| -8.1% |
| +16.2% |
| Total Liabilities | $1.00B | -8.7% | +5.9% |
| Stockholders' Equity | $1.90B | -8.6% | +12.0% |